{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:55:22Z","timestamp":1794545722399,"version":"4.9.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-74780-9","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:47:15Z","timestamp":1782222435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["MYDGF promotes pathological and physiological retinal angiogenesis via the G\u03b1i1\/3-Gab1-Akt-mTOR signaling"],"prefix":"10.1038","volume":"17","author":[{"given":"Ke-ran","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-ping","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1199-1432","authenticated-orcid":false,"given":"Wen","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-wen","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-long","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0541-4635","authenticated-orcid":false,"given":"Qin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0626-3501","authenticated-orcid":false,"given":"Zhou-rui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0034-6397","authenticated-orcid":false,"given":"Yu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0824-3472","authenticated-orcid":false,"given":"Cong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"74780_CR1","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00109-013-0993-5","volume":"91","author":"PA Campochiaro","year":"2013","unstructured":"Campochiaro, P. A. Ocular neovascularization. J. Mol. Med. 91, 311\u2013321 (2013).","journal-title":"J. Mol. Med."},{"key":"74780_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.preteyeres.2015.06.002","volume":"49","author":"PA Campochiaro","year":"2015","unstructured":"Campochiaro, P. A. Molecular pathogenesis of retinal and choroidal vascular diseases. Prog. Retin. Eye Res. 49, 67\u201381 (2015).","journal-title":"Prog. Retin. Eye Res."},{"key":"74780_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41574-020-00451-4","volume":"17","author":"DA Antonetti","year":"2021","unstructured":"Antonetti, D. A., Silva, P. S. & Stitt, A. W. Current understanding of the molecular and cellular pathology of diabetic retinopathy. Nat. Rev. Endocrinol. 17, 195\u2013206 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"74780_CR4","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/eye.2009.306","volume":"24","author":"A Scott","year":"2010","unstructured":"Scott, A. & Fruttiger, M. Oxygen-induced retinopathy: a model for vascular pathology in the retina. Eye 24, 416\u2013421 (2010).","journal-title":"Eye"},{"key":"74780_CR5","doi-asserted-by":"publisher","first-page":"xxiii","DOI":"10.1016\/j.ajo.2017.10.027","volume":"186","author":"P Sternberg Jr.","year":"2018","unstructured":"Sternberg, P. Jr. & Durrani, A. K. Evolving concepts in the management of retinopathy of prematurity. Am. J. Ophthalmol. 186, xxiii\u2013xxxii (2018).","journal-title":"Am. J. Ophthalmol."},{"key":"74780_CR6","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","volume":"376","author":"N Cheung","year":"2010","unstructured":"Cheung, N., Mitchell, P. & Wong, T. Y. Diabetic retinopathy. Lancet 376, 124\u2013136 (2010).","journal-title":"Lancet"},{"key":"74780_CR7","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/S0140-6736(20)31559-2","volume":"396","author":"IU Scott","year":"2020","unstructured":"Scott, I. U., Campochiaro, P. A., Newman, N. J. & Biousse, V. Retinal vascular occlusions. Lancet 396, 1927\u20131940 (2020).","journal-title":"Lancet"},{"key":"74780_CR8","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","volume":"382","author":"A Hellstr\u00f6m","year":"2013","unstructured":"Hellstr\u00f6m, A., Smith, L. E. & Dammann, O. Retinopathy of prematurity. Lancet 382, 1445\u20131457 (2013).","journal-title":"Lancet"},{"key":"74780_CR9","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/nature04482","volume":"438","author":"RF Gariano","year":"2005","unstructured":"Gariano, R. F. & Gardner, T. W. Retinal angiogenesis in development and disease. Nature 438, 960\u2013966 (2005).","journal-title":"Nature"},{"key":"74780_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.11.001","volume":"63","author":"S Selvam","year":"2018","unstructured":"Selvam, S., Kumar, T. & Fruttiger, M. Retinal vasculature development in health and disease. Prog. Retin Eye Res. 63, 1\u201319 (2018).","journal-title":"Prog. Retin Eye Res."},{"key":"74780_CR11","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41573-023-00671-z","volume":"22","author":"Y Cao","year":"2023","unstructured":"Cao, Y., Langer, R. & Ferrara, N. Targeting angiogenesis in oncology, ophthalmology and beyond. Nat. Rev. Drug Discov. 22, 476\u2013495 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"74780_CR12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1161\/CIRCRESAHA.120.316851","volume":"127","author":"G Eelen","year":"2020","unstructured":"Eelen, G., Treps, L., Li, X. & Carmeliet, P. Basic and therapeutic aspects of angiogenesis updated. Circ. Res. 127, 310\u2013329 (2020).","journal-title":"Circ. Res."},{"key":"74780_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.100954","volume":"84","author":"A Uemura","year":"2021","unstructured":"Uemura, A. et al. VEGFR1 signaling in retinal angiogenesis and microinflammation. Prog. Retin Eye Res. 84, 100954 (2021).","journal-title":"Prog. Retin Eye Res."},{"key":"74780_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1350-9462(02)00043-5","volume":"22","author":"AN Witmer","year":"2003","unstructured":"Witmer, A. N., Vrensen, G. F., Van Noorden, C. J. & Schlingemann, R. O. Vascular endothelial growth factors and angiogenesis in eye disease. Prog. Retin Eye Res. 22, 1\u201329 (2003).","journal-title":"Prog. Retin Eye Res."},{"key":"74780_CR15","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1172\/JCI126655","volume":"129","author":"A Rattner","year":"2019","unstructured":"Rattner, A., Williams, J. & Nathans, J. Roles of HIFs and VEGF in angiogenesis in the retina and brain. J. Clin. Investig. 129, 3807\u20133820 (2019).","journal-title":"J. Clin. Investig."},{"key":"74780_CR16","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/nm.3778","volume":"21","author":"M Korf-Klingebiel","year":"2015","unstructured":"Korf-Klingebiel, M. et al. Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction. Nat. Med. 21, 140\u2013149 (2015).","journal-title":"Nat. Med."},{"key":"74780_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cytogfr.2023.12.005","volume":"76","author":"J Xu","year":"2024","unstructured":"Xu, J. et al. Myeloid-derived growth factor and its effects on cardiovascular and metabolic diseases. Cytokine Growth Factor Rev. 76, 77\u201385 (2024).","journal-title":"Cytokine Growth Factor Rev."},{"key":"74780_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s10020-024-00874-z","volume":"30","author":"P Chen","year":"2024","unstructured":"Chen, P. et al. Myeloid-derived growth factor in diseases: structure, function and mechanisms. Mol. Med. 30, 103 (2024).","journal-title":"Mol. Med."},{"key":"74780_CR19","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nrd4557","volume":"14","author":"M Cully","year":"2015","unstructured":"Cully, M. Cardiovascular disease: MYDGF promotes heart repair after myocardial infarction. Nat. Rev. Drug Discov. 14, 164\u2013165 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"key":"74780_CR20","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s12265-025-10641-y","volume":"18","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. Mydgf enhances cardiac angiogenesis by upregulating FGF1. J. Cardiovasc. Transl. Res. 18, 775\u2013784 (2025).","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"74780_CR21","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1080\/00914037.2024.2302606","volume":"73","author":"S Huang","year":"2024","unstructured":"Huang, S. et al. GelMA - PVAMA hydrogel loaded with MYDGF accelerates wound healing by promoting angiogenesis. Int. J. Polym. Mater. Polym. Biomater. 73, 1569\u20131578 (2024).","journal-title":"Int. J. Polym. Mater. Polym. Biomater."},{"key":"74780_CR22","doi-asserted-by":"publisher","first-page":"762","DOI":"10.2337\/db21-0551","volume":"71","author":"Z Hu","year":"2022","unstructured":"Hu, Z. et al. Single-cell transcriptomics reveals novel role of microglia in fibrovascular membrane of proliferative diabetic retinopathy. Diabetes 71, 762\u2013773 (2022).","journal-title":"Diabetes"},{"key":"74780_CR23","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1002\/j.1460-2075.1996.tb00911.x","volume":"15","author":"GJ Brunn","year":"1996","unstructured":"Brunn, G. J. et al. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J. 15, 5256\u20135267 (1996).","journal-title":"EMBO J."},{"key":"74780_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn6928","volume":"8","author":"J Yao","year":"2022","unstructured":"Yao, J. et al. The requirement of phosphoenolpyruvate carboxykinase 1 for angiogenesis in vitro and in vivo. Sci. Adv. 8, eabn6928 (2022).","journal-title":"Sci. Adv."},{"key":"74780_CR25","first-page":"217","volume":"14","author":"G Xu","year":"2023","unstructured":"Xu, G. et al. Galphai1\/3 mediation of Akt-mTOR activation is important for RSPO3-induced angiogenesis. Protein Cell 14, 217\u2013222 (2023).","journal-title":"Protein Cell"},{"key":"74780_CR26","doi-asserted-by":"crossref","unstructured":"Binet, F. et al. Neutrophil extracellular traps target senescent vasculature for tissue remodeling in retinopathy. Science 369, eaay5356 (2020).","DOI":"10.1126\/science.aay5356"},{"key":"74780_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1387\/ijdb.103167dr","volume":"55","author":"D Ribatti","year":"2011","unstructured":"Ribatti, D., Nico, B. & Crivellato, E. The role of pericytes in angiogenesis. Int J. Dev. Biol. 55, 261\u2013268 (2011).","journal-title":"Int J. Dev. Biol."},{"key":"74780_CR28","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.7150\/ijbs.82855","volume":"19","author":"HJ Shan","year":"2023","unstructured":"Shan, H. J. et al. SCF\/c-Kit-activated signaling and angiogenesis require Galphai1 and Galphai3. Int J. Biol. Sci. 19, 1910\u20131924 (2023).","journal-title":"Int J. Biol. Sci."},{"key":"74780_CR29","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.cmet.2020.03.009","volume":"31","author":"K Rohlenova","year":"2020","unstructured":"Rohlenova, K. et al. Single-cell RNA sequencing maps endothelial metabolic plasticity in pathological angiogenesis. Cell Metab. 31, 862\u2013877 e814 (2020).","journal-title":"Cell Metab."},{"key":"74780_CR30","doi-asserted-by":"crossref","unstructured":"Duan, L. J, Jiang, Y. & Fong, G. H. Endothelial HIF2alpha suppresses retinal angiogenesis in neonatal mice by upregulating NOTCH signaling. Development 151, dev202802 (2024).","DOI":"10.1242\/dev.202802"},{"key":"74780_CR31","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/j.devcel.2021.06.021","volume":"56","author":"G Zarkada","year":"2021","unstructured":"Zarkada, G. et al. Specialized endothelial tip cells guide neuroretina vascularization and blood-retina-barrier formation. Dev. Cell 56, 2237\u20132251 e2236 (2021).","journal-title":"Dev. Cell"},{"key":"74780_CR32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/jid.2014.326","volume":"135","author":"YM Zhang","year":"2015","unstructured":"Zhang, Y. M. et al. Requirement of Galphai1\/3-Gab1 signaling complex for keratinocyte growth factor-induced PI3K-AKT-mTORC1 activation. J. Invest Dermatol 135, 181\u2013191 (2015).","journal-title":"J. Invest Dermatol"},{"key":"74780_CR33","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.7150\/thno.26203","volume":"8","author":"J Sun","year":"2018","unstructured":"Sun, J. et al. Galphai1 and Galphai3mediate VEGF-induced VEGFR2 endocytosis, signaling and angiogenesis. Theranostics 8, 4695\u20134709 (2018).","journal-title":"Theranostics"},{"key":"74780_CR34","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.7150\/thno.56383","volume":"11","author":"JY Bai","year":"2021","unstructured":"Bai, J. Y. et al. Requirement of Galphai1 and Galphai3 in interleukin-4-induced signaling, macrophage M2 polarization and allergic asthma response. Theranostics 11, 4894\u20134909 (2021).","journal-title":"Theranostics"},{"key":"74780_CR35","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.7150\/thno.80749","volume":"13","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Galphai1\/3 mediate Netrin-1-CD146-activated signaling and angiogenesis. Theranostics 13, 2319\u20132336 (2023).","journal-title":"Theranostics"},{"key":"74780_CR36","first-page":"223","volume":"14","author":"F Liu","year":"2023","unstructured":"Liu, F. et al. YME1L overexpression exerts pro-tumorigenic activity in glioma by promoting Galphai1 expression and Akt activation. Protein Cell 14, 223\u2013229 (2023).","journal-title":"Protein Cell"},{"key":"74780_CR37","doi-asserted-by":"publisher","first-page":"5667","DOI":"10.7150\/ijbs.77126","volume":"18","author":"J Zhang","year":"2022","unstructured":"Zhang, J. et al. Identification of Galphai3 as a novel molecular therapeutic target of cervical cancer. Int J. Biol. Sci. 18, 5667\u20135680 (2022).","journal-title":"Int J. Biol. Sci."},{"key":"74780_CR38","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.7150\/ijbs.68861","volume":"18","author":"ZJ Bian","year":"2022","unstructured":"Bian, Z. J. et al. Identification of Galphai3 as a promising target for osteosarcoma treatment. Int J. Biol. Sci. 18, 1508\u20131520 (2022).","journal-title":"Int J. Biol. Sci."},{"key":"74780_CR39","doi-asserted-by":"publisher","first-page":"ra17","DOI":"10.1126\/scisignal.2000118","volume":"2","author":"C Cao","year":"2009","unstructured":"Cao, C. et al. Galpha(i1) and Galpha(i3) are required for epidermal growth factor-mediated activation of the Akt-mTORC1 pathway. Sci. Signal 2, ra17 (2009).","journal-title":"Sci. Signal"},{"key":"74780_CR40","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/379560a0","volume":"379","author":"M Holgado-Madruga","year":"1996","unstructured":"Holgado-Madruga, M., Emlet, D. R., Moscatello, D. K., Godwin, A. K. & Wong, A. J. A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature 379, 560\u2013564 (1996).","journal-title":"Nature"},{"key":"74780_CR41","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1210\/mend.12.7.0141","volume":"12","author":"S Rocchi","year":"1998","unstructured":"Rocchi, S. et al. Determination of Gab1 (Grb2-associated binder-1) interaction with insulin receptor-signaling molecules. Mol. Endocrinol. 12, 914\u2013923 (1998).","journal-title":"Mol. Endocrinol."},{"key":"74780_CR42","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1002\/hep.21900","volume":"46","author":"Z Wang","year":"2007","unstructured":"Wang, Z., Ge, L., Wang, M. & Carr, B. I. Grb2-associated binder-1 plays a central role in the hepatocyte growth factor enhancement of hepatoma growth inhibition by K vitamin analog compound 5. Hepatology 46, 2003\u20132013 (2007).","journal-title":"Hepatology"},{"key":"74780_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44760-y","volume":"15","author":"L Grosse-Segerath","year":"2024","unstructured":"Grosse-Segerath, L. et al. Identification of myeloid-derived growth factor as a mechanically-induced, growth-promoting angiocrine signal for human hepatocytes. Nat. Commun. 15, 1076 (2024).","journal-title":"Nat. Commun."},{"key":"74780_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13343-7","volume":"10","author":"R Ebenhoch","year":"2019","unstructured":"Ebenhoch, R. et al. Crystal structure and receptor-interacting residues of MYDGF - a protein mediating ischemic tissue repair. Nat. Commun. 10, 5379 (2019).","journal-title":"Nat. Commun."},{"key":"74780_CR45","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1248\/bpb.b212024","volume":"35","author":"T Katada","year":"2012","unstructured":"Katada, T. The inhibitory G protein G(i) identified as pertussis toxin-catalyzed ADP-ribosylation. Biol. Pharm. Bull. 35, 2103\u20132111 (2012).","journal-title":"Biol. Pharm. Bull."},{"key":"74780_CR46","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0301-2115(99)00134-7","volume":"88","author":"E Daiter","year":"2000","unstructured":"Daiter, E., Makrigiannakis, A., Coukos, G., Woolkalis, M. J. & Coutifaris, C. Inhibitory G protein alpha subunit (Gi alpha) expression and localization during human trophoblast differentiation. Eur. J. Obstet. Gynecol. Reprod. Biol. 88, 165\u2013169 (2000).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74780-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74780-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74780-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:02:28Z","timestamp":1786014148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74780-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74780"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74780-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"17 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"7889"}}